Comprehensive Center for Brain Health
Charles E. Schmidt College of Medicine
Florida Atlantic University
777 Glades Road
Boca Raton, FL 33431
Our clinicians are involved in active research projects developing, testing, and studying new diagnostics and treatments. Recommendations for research opportunities tailored to the specific needs of the patient.
Dr. Galvin’s research has been funded by the: National Institutes of Health, Center for Disease Control, Florida Department of Health, Alzheimer’s Association, American Federation for Aging Research, Michael J Fox Foundation, Association for Frontotemporal Degeneration, Lewy Body Dementia Association, Alzheimer Drug Discovery Fund, and numerous private and family foundations.
Dr Galvin has led over 50 clinical trials testing novel agents for the treatment and prevention of Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, and Frontotemporal degeneration. We are currently enrolling individuals with memory impairments as well as healthy controls for many of these studies ( attach link to clinical trial matrix )
Multicultural Community Dementia Screening : The major goals of this project are to provide cross-cultural validation of dementia screening methods and biological validation against imaging and CSF biomarkers of Alzheimer disease and related disorders.
Dementia with Lewy Bodies Consortium: The major goals of this project is to develop a national network to study dementia with Lewy bodies including longitudinal clinical and cognitive characterization, imaging and CSF biomarkers, and autopsy.
The Dementia Prevention Initiative: The major goal of this project is to develop a dementia prevention initiative using a precision medicine approach with personalized tailored interventions in deeply phenotyped individuals.
LRRK2-002: The major goals of this study is to characterize the role of LRRK2 mutation in the onset and progression of Parkinson’s disease.